Quarter Period Consolidated Statement Of Income

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7577431

Concept 2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
Quarter period consolidated statement of income
Statement of income
Net sales
5,187,000,000 JPY
41,916,000,000 JPY
47,300,000,000 JPY
-41,000,000 JPY
47,259,000,000 JPY
196,000,000 JPY
44,179,000,000 JPY
44,221,000,000 JPY
-41,000,000 JPY
4,377,000,000 JPY
39,685,000,000 JPY
158,000,000 JPY
Cost of sales
24,893,000,000 JPY
23,485,000,000 JPY
Gross profit (loss)
22,366,000,000 JPY
20,694,000,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
17,324,000,000 JPY
16,017,000,000 JPY
Operating profit (loss)
417,000,000 JPY
5,418,000,000 JPY
5,809,000,000 JPY
-767,000,000 JPY
5,041,000,000 JPY
-26,000,000 JPY
4,677,000,000 JPY
5,173,000,000 JPY
-495,000,000 JPY
329,000,000 JPY
4,886,000,000 JPY
-42,000,000 JPY
Non-operating income
Interest income
0 JPY
0 JPY
Dividend income
331,000,000 JPY
251,000,000 JPY
Non-operating income
402,000,000 JPY
367,000,000 JPY
Non-operating expenses
Interest expenses
38,000,000 JPY
43,000,000 JPY
Non-operating expenses
197,000,000 JPY
254,000,000 JPY
Ordinary profit (loss)
5,246,000,000 JPY
4,790,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
JPY
9,425,000,000 JPY
Extraordinary income
121,000,000 JPY
9,425,000,000 JPY
Extraordinary losses
Impairment losses
JPY
5,921,000,000 JPY
Extraordinary losses
JPY
8,366,000,000 JPY
Profit (loss) before income taxes
5,367,000,000 JPY
5,849,000,000 JPY
Income taxes - current
1,036,000,000 JPY
1,048,000,000 JPY
Income taxes - deferred
148,000,000 JPY
717,000,000 JPY
Income taxes
1,184,000,000 JPY
1,766,000,000 JPY
Profit (loss)
4,183,000,000 JPY
4,082,000,000 JPY
Profit attributable to
Profit (loss) attributable to owners of parent
4,183,000,000 JPY
4,082,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
858,000,000 JPY
61,000,000 JPY
Remeasurements of defined benefit plans, net of tax
20,000,000 JPY
22,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
477,000,000 JPY
89,000,000 JPY
Other comprehensive income
1,355,000,000 JPY
173,000,000 JPY
Comprehensive income
5,538,000,000 JPY
4,256,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
5,538,000,000 JPY
4,256,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.